Table: diabetes_ndcs_wac_increases_5_year_history , manufacturer_name like N*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

year_str	oshpd_id	manufacturer_name	date_reported	ndc_number	drug_product_description	wac_effective_date	wac_increase_amount	wac_after_increase	patent_expiration_date	drug_source_type	unit_sales_volume_in_us	unit_sales_volume_non_public_indicator	cost_increase_factors	cost_increase_factors_non_public_indicator	change_improvement_description	change_improvement_non_public_indicator	acquisition_date	company_acquired_from	acquisition_price	acquisition_price_non_public_indicator	acquisition_price_comment	wac_at_acquisition	wac_year_prior_to_acquisition	year_drug_introduced_to_market	wac_at_intro_to_market	supporting_documents	general_comments
2019	Rx0000033	Novo	03/31/2019	00169406012	Victoza? 6mg/mL 2x3mL	01/08/2019	34.26	614.52	08/22/2022	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Victoza. We've included the expiration date for Patent #6268343 which is the compound patent for Victoza. NNI has applied for pediatric exclusivity. If granted, this will add 6 months to all Orange Book exclusivities. NNI is the original manufacturer of this product (Victoza) and did not acquire the product from a different company.
2019	Rx0000033	Novo	03/31/2019	169406013	Victoza? 6mg/mL 3x3mL	01/08/2019	51.39	921.78	08/22/2022	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Victoza. We've included the expiration date for Patent #6268343 which is the compound patent for Victoza. NNI has applied for pediatric exclusivity. If granted, this will add 6 months to all Orange Book exclusivities. NNI is the original manufacturer of this product (Victoza) and did not acquire the product from a different company.
2020	Rx0000033	Novo	03/31/2020	00169406012	Victoza 6mg/mL 2x3mL Prefilled Pens	01/10/2020	30.72	645.24	07/09/2037	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Victoza. We've included the expiration date for Patent #9968659 which is the patent with the latest expiry date in the FDA Orange Book. NNI is the original manufacturer of Victoza and did not acquire the product from a different company.
2020	Rx0000033	Novo	03/31/2020	00169406013	Victoza 6mg/mL 3x3mL Prefilled Pens	01/10/2020	46.08	967.86	07/09/2037	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Victoza. We've included the expiration date for Patent #9968659 which is the patent with the latest expiry date in the FDA Orange Book. NNI is the original manufacturer of Victoza and did not acquire the product from a different company.
2020	Rx0000033	Novo	03/31/2020	00169413212	Ozempic (0.25 or 0.5 MG/DOSE) Subcutaneous Solution Pen-injector 2 MG/1.5ML	01/10/2020	38.62	811.05	06/21/2033	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Ozempic and has included the expiration date for Patent #10335462 which is the patent with the latest expiry date in the FDA Orange Book. NNI is the original manufacturer of Ozempic and did not acquire the product from a different company.
2020	Rx0000033	Novo	03/31/2020	00169413602	Ozempic (1 MG/DOSE) Subcutaneous Solution Pen-injector 2 MG/1.5ML	01/10/2020	38.62	811.05	06/21/2033	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	NNI holds a number of patents related to Ozempic and has included the expiration date for Patent #10335462 which is the patent with the latest expiry date in the FDA Orange Book. NNI is the original manufacturer of Ozempic and did not acquire the product from a different company.